Novavax Inc. (NVAX)
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Novavax (NVAX) closed at $12.91, indicating a +1.77% shift from the previous trading day.
EU authorizes Novavax's updated COVID vaccine targeting JN.1 strain
The European Union authorized Novavax's updated COVID vaccine targeting the JN.1 strain of coronavirus, the company said on Wednesday.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Stock Dips Amidst Volatility in Biotech Sector
Shares of Novavax (NVAX, Financial), a biotechnology firm specializing in vaccine development, experienced a significant drop of 5.11%. The stock is currently priced at $12.92 with a trading volume of approximately 3.03 million shares, reflecting a turnover rate of 1.89% and a price fluctuation of 6.10%.
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
In the most recent trading session, Novavax (NVAX) closed at $12.80, indicating a -0.85% shift from the previous trading day.
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects in the industry.
Is Novavax Stock A Buy On A Vaccines Rally Following Bullish Moderna News?
Is Novavax stock a buy after vaccine stocks surged on bullish news from Moderna? Is NVAX stock a buy right now?
Should You Buy Novavax Stock After This Regulatory Win?
Novavax received emergency use authorization for an updated vaccine. The biotech is benefiting from a partnership with Sanofi.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)
Novavax, Inc. (NASDAQ:NVAX ) Baird 2024 Global Healthcare Conference September 10, 2024 3:10 PM ET Unidentified Company Representative I'd like to thank you all for joining us for Novavax Corporate presentation certainly for Baird for having us here again this year. This is always such a great forum and it coincides with the beginning of the vaccination season for COVID vaccines.
